(Q46528960)

22 December 2017

title

The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis (English)

1 reference

22 December 2017

4

Lionel H Opie

1 reference

22 December 2017

Miguel A Frias

1

1 reference

22 December 2017

Sarin Somers

2

1 reference

22 December 2017

Christine Gerber-Wicht

3

1 reference

22 December 2017

Sandrine Lecour

5

1 reference

22 December 2017

Ursula Lang

6

1 reference

22 December 2017

publication date

20 June 2008

1 reference

22 December 2017

published in

Cardiovascular Research

1 reference

22 December 2017

volume

80

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

69-77

1 reference

22 December 2017

Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN171

Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN171

Adriamycin-induced heart failure: mechanism and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN171

Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN171

Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN171

Disruption of COX-2 modulates gene expression and the cardiac injury response to doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN171

Mechanism of cyclooxygenase-2 upregulation in late preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN171

Oxidative stress-elicited myocardial apoptosis during reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN171

Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN171

Many good reasons to have STAT3 in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN171

Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN171

Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN171

Prostaglandin E2 activates Stat3 in neonatal rat ventricular cardiomyocytes: A role in cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN171

Specificity and mechanism of action of some commonly used protein kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN171

Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN171

p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN171

Distinct mechanisms of STAT phosphorylation via the interferon-alpha/beta receptor. Selective inhibition of STAT3 and STAT5 by piceatannol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN171

STRESS signaling pathways that modulate cardiac myocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN171

Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN171

Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN171

21 January 2018

Identifiers

DOI

10.1093/CVR/CVN171

1 reference

22 December 2017

PubMed ID

18567640

1 reference

22 December 2017